-transparent.png){kind=logo}
The metabolic pathway of the dopaminagonistic ergoline derivative, proterguride, was studied in vitro in a rat liver perfusion experiment. Metabolites were isolated by preparative HPLC and identified by MS and NMR analyses. In total, seven compounds could be identified. The metabolic steps involved in the biodegradation of proterguride are N-deethylation, N-oxidation, hydroxylation, and/or dehydrogenation and oxidative cleavage of the indole ring.
Related Publications
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1992,
Yao xue xue bao = Acta pharmaceutica Sinica,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1978,
Biochemical pharmacology,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1990,
Yao xue xue bao = Acta pharmaceutica Sinica,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1980,
Xenobiotica; the fate of foreign compounds in biological systems,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1999,
Acta medica (Hradec Kralove),
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
September 1985,
Mycotoxin research,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1998,
Anticancer research,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
January 1981,
Drug metabolism and disposition: the biological fate of chemicals,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
March 2020,
Pesticide biochemistry and physiology,
W Krause, and
B Düsterberg, and
U Jakobs, and
G A Hoyer
March 1988,
Biochemical pharmacology,
